Silverback Therapeutics, Inc.·4

May 4, 5:16 PM ET

Piazza Jonathan 4

4 · Silverback Therapeutics, Inc. · Filed May 4, 2022

Insider Transaction Report

Form 4
Period: 2022-05-02
Piazza Jonathan
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-05-02+43,69169,225 total
  • Award

    Stock Option (right to buy)

    2022-05-02+87,38387,383 total
    Exercise: $3.15Exp: 2032-05-01Common Stock (87,383 underlying)
Footnotes (2)
  • [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The shares subject to the option will vest on May 2, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION